An ultrasound training program developed in Houston for non-physicians is giving astronauts and sports trainers a way to better assess injuries.
Researchers with the National Space Biomedical Research Institute say they've developed the computer-based training method to instruct non-physicians in operating ultrasound equipment as if they were technicians.
Crew members for four International Space Station missions have trained with the program and the ultrasound program also has been used by trainers with the Detroit Red Wings hockey team.
Dr. Scott Dulchavsky, a NSBRI researcher, said. "Our goal is to enable someone working in a remote environment to assess and manage an emergency medical condition."
In space, ultrasound can be used to assess a number of injuries such as trauma to the eye, shoulder or knee, tooth abscesses, broken or fractured bones, a collapsed lung, hemorrhaging, or muscle and bone atrophy, Dulchavsky said.
It normally takes 200 hours, plus yearly updates, to learn to operate ultrasound, but Dulchavsky and his team developed an education method that cuts the time to about three hours a year.
Dulchavsky also sees the ultrasound training method as beneficial to battlefield medics and emergency responders.
Copyright 2005 by United Press International
Related stories:
Joyful music may promote heart health
Listening to your favorite music may be good for your cardiovascular system. Researchers at the University of Maryland School of Medicine in Baltimore have shown for the first time that the emotions aroused by joyful music have a healthy effect on blood vessel function.
Sensitive ultrasound to spot early-stage cancer
(PhysOrg.com) -- European researchers have developed highly sensitive ultrasound equipment that can detect tiny quantities of reflective microbubbles engineered to stick to specific tumour cells. The technique should pick up tumours early and improve patients' chances of survival.
Drug may reduce coronary artery plaque
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque.
New system devised to guide doctors treating patients with symptomatic myocardial bridging
What type of intervention, if any, should cardiologists offer their patients who have a heart abnormality called myocardial bridging and symptoms of heart problems?
Accuracy of ultrasound screening in pregnancy: Effects of examiner and device quality unclear
Only indications of positive associations; no studies on the German health care setting available
International studies indicate that there is an association between examiner qualifications and device quality on the one hand, and detection rates of ultrasound screening tests in pregnancy on the other. However, it is unclear which minimum preconditions must be fulfilled in order to achieve sufficiently high detection rates for major foetal abnormalities.
Simple ultrasound exam may predict osteoporosis risk
OAK BROOK, Ill. – An ultrasound exam of the heel may be able to predict if a woman is at heightened risk for fractures due to osteoporosis, according to a new multicenter study being published in the July issue of the journal
Radiology. Along with certain risk factors, including age or recent fall, radiation-free ultrasound of the heel may be used to better select women who need further bone density testing, such as a dual-energy x-ray absorptiometry (DXA) exam.
Symptom screening plus a simple blood test improves early detection of ovarian cancer
Women's reports of persistent, recent-onset symptoms linked to ovarian cancer – abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating – when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online in
CANCER.
Mixed results for weight loss drug on slowing progression of coronary disease
The anti-obesity medication rimonabant showed mixed results in slowing progression of coronary artery disease in patients with abdominal obesity and pre-existing coronary disease, according to a new study in the April 2 issue of JAMA. The study is being released early online April 1 to coincide with its presentation at the annual conference of the American College of Cardiology.